Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook
(NASDAQ:BBLG) BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (âBone Biologicsâ or the âCompanyâ) (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion market...
2 days ago